Particle characteristics such as shape or surface structure, as well as the overall morphology, are often correlated to the efficacy of the end gene therapy drug or vaccine product.
EM is an ideal technology to truly understand the effects on particle morphology when you change your upstream or downstream process or product formulation.
Contact
Vironova AB
Gävlegatan 22
113 30 Stockholm
SWEDEN
E-mail: info@vironova.com